HEPION PHARMACEUTICALS, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2014 | $-1.4M | $-1.4M | $15.8K | $195.2K |
| FY2015 | $-9.7M | $-9.8M | $83.3K | $2.1M |
| FY2016 | $-16.6M | $-16.6M | $6.6K | $901.9K |
| FY2017 | $-19.2M | $-19.2M | $14.7K | $1.7M |
| FY2018 | $-15.6M | $-15.6M | — | $234.5K |
| FY2019 | $-7.6M | $-7.6M | $51.5K | $66.2K |
| FY2020 | $-16.2M | $-16.3M | $88.0K | $2.4M |
| FY2021 | $-31.2M | $-31.4M | $130.4K | $4.7M |
| FY2022 | $-35.0M | $-35.0M | $16.3K | $2.6M |
| FY2023 | $-40.9M | $-40.9M | $14.3K | $1.3M |
| FY2024 | $-18.2M | $-18.2M | — | $791.6K |
| FY2025 | $-3.3M | $-3.3M | — | $20.8K |